Guidelines for the content and format of PET brain data in publications and archives: A consensus paper.
J Cereb Blood Flow Metab.
2020 Aug;40(8):1576-1585. doi: 10.1177/0271678X20905433. Epub 2020 Feb 16. PubMed PMID:
32065076; PubMed Central PMCID:
PMC7370374.
A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia.
Neuropsychopharmacology.
2020 Apr;45(5):786-792. doi: 10.1038/s41386-019-0590-6. Epub 2019 Dec 17. PubMed PMID:
31847007; PubMed Central PMCID:
PMC7075883.
Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot study.
J Affect Disord.
2020 Mar 15;265:439-444. doi: 10.1016/j.jad.2020.01.066. Epub 2020 Jan 15. PubMed PMID:
32090770; PubMed Central PMCID:
PMC7042346.
Baseline reward processing and ventrostriatal dopamine function are associated with pramipexole response in depression.
Brain.
2020 Feb 1;143(2):701-710. doi: 10.1093/brain/awaa002. PubMed PMID:
32040562; PubMed Central PMCID:
PMC7009463.
Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO.
Psychopharmacology (Berl).
2020 Feb;237(2):519-527. doi: 10.1007/s00213-019-05387-w. Epub 2019 Nov 26. PubMed PMID:
31773210.
Binge alcohol use is not associated with alterations in striatal dopamine receptor binding or dopamine release.
Drug Alcohol Depend.
2019 Dec 1;205:107627. doi: 10.1016/j.drugalcdep.2019.107627. Epub 2019 Oct 17. PubMed PMID:
31669800; PubMed Central PMCID:
PMC6893096.
Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.
Neuropsychopharmacology.
2019 Sep;44(10):1720-1727. doi: 10.1038/s41386-019-0398-4. Epub 2019 Apr 26. PubMed PMID:
31026862; PubMed Central PMCID:
PMC6785004.
Effects of L-DOPA Monotherapy on Psychomotor Speed and [11C]Raclopride Binding in High-Risk Older Adults With Depression.
Biol Psychiatry.
2019 Aug 1;86(3):221-229. doi: 10.1016/j.biopsych.2019.04.007. Epub 2019 Apr 15. PubMed PMID:
31178096; PubMed Central PMCID:
PMC6641997.
A role for foregut tyrosine metabolism in glucose tolerance.
Mol Metab.
2019 May;23:37-50. doi: 10.1016/j.molmet.2019.02.008. Epub 2019 Feb 27. PubMed PMID:
30876866; PubMed Central PMCID:
PMC6479665.
Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres.
J Cereb Blood Flow Metab.
2019 Feb;39(2):210-222. doi: 10.1177/0271678X18770107. Epub 2018 Apr 13. PubMed PMID:
29651896; PubMed Central PMCID:
PMC6365604.
Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [11C]-(+)-PHNO Positron Emission Tomography and Functional Magnetic Resonance Imaging Study.
Biol Psychiatry.
2018 Oct 15;84(8):563-573. doi: 10.1016/j.biopsych.2018.05.014. Epub 2018 May 25. PubMed PMID:
30041971; PubMed Central PMCID:
PMC6347467.
Enhanced Striatal Dopamine Release to Expectation of Alcohol: A Potential Risk Factor for Alcohol Use Disorder.
Biol Psychiatry Cogn Neurosci Neuroimaging.
2018 Jul;3(7):591-598. doi: 10.1016/j.bpsc.2018.03.018. Epub 2018 Apr 21. PubMed PMID:
29803635; PubMed Central PMCID:
PMC6953614.
PET imaging of dopamine-D2 receptor internalization in schizophrenia.
Mol Psychiatry.
2018 Jun;23(6):1506-1511. doi: 10.1038/mp.2017.107. Epub 2017 May 16. PubMed PMID:
28507321; PubMed Central PMCID:
PMC5690884.
Is it Pre- or Postsynaptic? Imaging Striatal Dopamine Excess in Schizophrenia.
Biol Psychiatry.
2018 Apr 15;83(8):635-637. doi: 10.1016/j.biopsych.2018.02.015. PubMed PMID:
29559095.
A Perceptual Inference Mechanism for Hallucinations Linked to Striatal Dopamine.
Curr Biol.
2018 Feb 19;28(4):503-514.e4. doi: 10.1016/j.cub.2017.12.059. Epub 2018 Feb 2. PubMed PMID:
29398218; PubMed Central PMCID:
PMC5820222.
PET imaging of dopamine-D2 receptor internalization in schizophrenia.
Mol Psychiatry.
2017 Jul 25;. doi: 10.1038/mp.2017.157. [Epub ahead of print] PubMed PMID:
29155803.
Deficits in striatal dopamine release in cannabis dependence.
Mol Psychiatry.
2017 Jan;22(1):68-75. doi: 10.1038/mp.2016.21. Epub 2016 Mar 22. PubMed PMID:
27001613; PubMed Central PMCID:
PMC5033654.
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
Biol Psychiatry.
2017 Jan 1;81(1):31-42. doi: 10.1016/j.biopsych.2016.03.2104. Epub 2016 Mar 31. Review. PubMed PMID:
27206569; PubMed Central PMCID:
PMC5177794.
Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders.
Semin Nucl Med.
2017 Jan;47(1):54-63. doi: 10.1053/j.semnuclmed.2016.09.002. Epub 2016 Oct 13. Review. PubMed PMID:
27987558.
Mechanisms of Working Memory Impairment in Schizophrenia.
Biol Psychiatry.
2016 Oct 15;80(8):617-26. doi: 10.1016/j.biopsych.2016.02.017. Epub 2016 Feb 23. PubMed PMID:
27056754; PubMed Central PMCID:
PMC4995154.
Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO.
Psychopharmacology (Berl).
2016 Oct;233(19-20):3503-12. doi: 10.1007/s00213-016-4382-y. Epub 2016 Aug 15. PubMed PMID:
27525990; PubMed Central PMCID:
PMC5035321.
Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
JAMA Psychiatry.
2016 Aug 1;73(8):862-70. doi: 10.1001/jamapsychiatry.2016.0178. PubMed PMID:
27145361; PubMed Central PMCID:
PMC5310843.
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia.
J Psychopharmacol.
2016 May;30(5):428-35. doi: 10.1177/0269881116636120. Epub 2016 Mar 10. PubMed PMID:
26966119.
Dynamic Connectivity between Brain Networks Supports Working Memory: Relationships to Dopamine Release and Schizophrenia.
J Neurosci.
2016 Apr 13;36(15):4377-88. doi: 10.1523/JNEUROSCI.3296-15.2016. PubMed PMID:
27076432; PubMed Central PMCID:
PMC4829655.
Quantitative imaging of protein targets in the human brain with PET.
Phys Med Biol.
2015 Nov 21;60(22):R363-411. doi: 10.1088/0031-9155/60/22/R363. Epub 2015 Oct 29. PubMed PMID:
26513176; NIHMSID:NIHMS735413.
Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNO.
Schizophr Res.
2015 Oct;168(1-2):373-6. doi: 10.1016/j.schres.2015.06.027. Epub 2015 Jul 17. PubMed PMID:
26190300; PubMed Central PMCID:
PMC4591174.
Striatal dopamine type 2 receptor availability in anorexia nervosa.
Psychiatry Res.
2015 Sep 30;233(3):380-7. doi: 10.1016/j.pscychresns.2015.06.013. Epub 2015 Jul 26. PubMed PMID:
26272038; PubMed Central PMCID:
PMC5055757.
Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
Nucl Med Biol.
2015 Aug;42(8):654-63. doi: 10.1016/j.nucmedbio.2015.04.004. Epub 2015 Apr 16. PubMed PMID:
25935386.
Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.
Psychiatry Res.
2015 Apr 30;232(1):65-70. doi: 10.1016/j.pscychresns.2015.01.009. Epub 2015 Feb 3. PubMed PMID:
25715904; PubMed Central PMCID:
PMC4404189.
Dynamic shifts in brain network activation during supracapacity working memory task performance.
Hum Brain Mapp.
2015 Apr;36(4):1245-64. doi: 10.1002/hbm.22699. Epub 2014 Nov 24. PubMed PMID:
25422039; PubMed Central PMCID:
PMC4722876.
Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
JAMA Psychiatry.
2015 Apr;72(4):316-24. doi: 10.1001/jamapsychiatry.2014.2414. PubMed PMID:
25651194; PubMed Central PMCID:
PMC4768742.
An evaluation of the brain distribution of [(11)C]GSK1034702, a muscarinic-1 (M 1) positive allosteric modulator in the living human brain using positron emission tomography.
EJNMMI Res.
2014 Dec;4(1):66. doi: 10.1186/s13550-014-0066-y. Epub 2014 Dec 5. PubMed PMID:
26116126; PubMed Central PMCID:
PMC4452589.
Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB.
J Psychiatr Res.
2014 Nov;58:147-54. doi: 10.1016/j.jpsychires.2014.07.025. Epub 2014 Aug 6. PubMed PMID:
25145808.
Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112.
Psychopharmacology (Berl).
2014 Oct;231(21):4231-40. doi: 10.1007/s00213-014-3566-6. Epub 2014 Apr 30. PubMed PMID:
24781514; PubMed Central PMCID:
PMC4194223.
Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictors.
Drug Alcohol Depend.
2014 Oct 1;143:29-35. doi: 10.1016/j.drugalcdep.2014.04.030. Epub 2014 Jul 10. PubMed PMID:
25108585; PubMed Central PMCID:
PMC4358761.
Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates.
Nucl Med Biol.
2014 Apr;41(4):343-9. doi: 10.1016/j.nucmedbio.2014.01.007. Epub 2014 Jan 17. PubMed PMID:
24607437.
Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy.
Biol Psychiatry.
2014 Jan 15;75(2):165-71. doi: 10.1016/j.biopsych.2013.06.026. Epub 2013 Sep 12. PubMed PMID:
24035345; PubMed Central PMCID:
PMC4106018.
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.
Mol Psychiatry.
2014 Jan;19(1):20-9. doi: 10.1038/mp.2013.136. Epub 2013 Oct 29. Review. PubMed PMID:
24166406.
Molecular imaging in alcohol dependence.
Handb Clin Neurol.
2014;125:293-311. doi: 10.1016/B978-0-444-62619-6.00018-5. Review. PubMed PMID:
25307582.
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography.
J Pharmacol Exp Ther.
2013 Aug;346(2):311-7. doi: 10.1124/jpet.112.202895. Epub 2013 May 17. PubMed PMID:
23685546.
Striatal dopamine release in schizophrenia comorbid with substance dependence.
Mol Psychiatry.
2013 Aug;18(8):909-15. doi: 10.1038/mp.2012.109. Epub 2012 Aug 7. PubMed PMID:
22869037; PubMed Central PMCID:
PMC4128915.
In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia.
Psychopharmacology (Berl).
2013 Jul;228(1):167-74. doi: 10.1007/s00213-013-3026-8. Epub 2013 Mar 5. PubMed PMID:
23460265.
Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
Neuropsychopharmacology.
2012 Nov;37(12):2684-92. doi: 10.1038/npp.2012.132. Epub 2012 Aug 1. PubMed PMID:
22850733; PubMed Central PMCID:
PMC3473334.
The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Arch Gen Psychiatry.
2012 Aug;69(8):776-86. doi: 10.1001/archgenpsychiatry.2012.169. PubMed PMID:
22474070; PubMed Central PMCID:
PMC3730746.
Striatal dopamine in bulimia nervosa: a PET imaging study.
Int J Eat Disord.
2012 Jul;45(5):648-56. doi: 10.1002/eat.20984. Epub 2012 Feb 13. PubMed PMID:
22331810; PubMed Central PMCID:
PMC3640453.
Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo.
Synapse.
2012 Jun;66(6):489-500. doi: 10.1002/syn.21535. Epub 2012 Feb 24. PubMed PMID:
22213512.
Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112.
J Psychopharmacol.
2012 Jun;26(6):794-805. doi: 10.1177/0269881111409265. Epub 2011 Jul 18. PubMed PMID:
21768159.
Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
Neuropsychopharmacology.
2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332. Epub 2012 Feb 22. PubMed PMID:
22353758; PubMed Central PMCID:
PMC3327851.
Imaging human reward processing with positron emission tomography and functional magnetic resonance imaging.
Psychopharmacology (Berl).
2012 May;221(1):67-77. doi: 10.1007/s00213-011-2543-6. Epub 2011 Nov 4. PubMed PMID:
22052081.
Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
Arch Gen Psychiatry.
2012 May;69(5):449-59. doi: 10.1001/archgenpsychiatry.2011.1519. Epub 2012 Jan 2. PubMed PMID:
22213769; NIHMSID:NIHMS352541.
What would you like to do?